DK1831237T3 - Amidprolægemiddel af gemcitabin, sammensætninger og anvendelse deraf - Google Patents

Amidprolægemiddel af gemcitabin, sammensætninger og anvendelse deraf

Info

Publication number
DK1831237T3
DK1831237T3 DK05852411T DK05852411T DK1831237T3 DK 1831237 T3 DK1831237 T3 DK 1831237T3 DK 05852411 T DK05852411 T DK 05852411T DK 05852411 T DK05852411 T DK 05852411T DK 1831237 T3 DK1831237 T3 DK 1831237T3
Authority
DK
Denmark
Prior art keywords
gemcitabine
compositions
promoter
amide
amide promoter
Prior art date
Application number
DK05852411T
Other languages
Danish (da)
English (en)
Inventor
David Michael Bender
David Michael Remick
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1831237T3 publication Critical patent/DK1831237T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK05852411T 2004-12-17 2005-11-30 Amidprolægemiddel af gemcitabin, sammensætninger og anvendelse deraf DK1831237T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (en) 2004-12-17 2005-11-30 Amide prodrug of gemcitabine, compositions and use thereof

Publications (1)

Publication Number Publication Date
DK1831237T3 true DK1831237T3 (da) 2008-10-27

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05852411T DK1831237T3 (da) 2004-12-17 2005-11-30 Amidprolægemiddel af gemcitabin, sammensætninger og anvendelse deraf

Country Status (32)

Country Link
US (1) US7691827B2 (ru)
EP (1) EP1831237B1 (ru)
JP (1) JP5022911B2 (ru)
KR (1) KR100874052B1 (ru)
CN (1) CN101080417B (ru)
AR (1) AR055009A1 (ru)
AT (1) ATE405573T1 (ru)
AU (1) AU2005316922B2 (ru)
BR (1) BRPI0519117A2 (ru)
CA (1) CA2589850C (ru)
CY (1) CY1108447T1 (ru)
DE (1) DE602005009255D1 (ru)
DK (1) DK1831237T3 (ru)
EA (1) EA011868B1 (ru)
ES (1) ES2310860T3 (ru)
HK (1) HK1109903A1 (ru)
HR (1) HRP20080529T3 (ru)
IL (1) IL183666A (ru)
MA (1) MA29154B1 (ru)
MX (1) MX2007007228A (ru)
MY (1) MY143677A (ru)
NO (1) NO20073368L (ru)
NZ (1) NZ554732A (ru)
PE (1) PE20060771A1 (ru)
PL (1) PL1831237T3 (ru)
PT (1) PT1831237E (ru)
RS (1) RS50629B (ru)
SI (1) SI1831237T1 (ru)
TW (1) TWI326687B (ru)
UA (1) UA86119C2 (ru)
WO (1) WO2006065525A1 (ru)
ZA (1) ZA200705019B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114854B2 (en) 2006-06-21 2012-02-14 Eli Lilly And Company Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
JP2015536954A (ja) 2012-11-07 2015-12-24 ズカイ スオ 置換ゲムシタビンアリールアミド類似体
BR112015010941A2 (pt) 2012-11-13 2017-07-11 Boyen Therapeutics Inc pró-fármacos de gemcitabina e suas utilizações
WO2015134334A1 (en) * 2014-03-03 2015-09-11 Suo Zucai Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
CA3088287A1 (en) 2018-01-10 2019-07-18 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
AU2019216531A1 (en) 2018-02-02 2020-09-24 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate
CN113166189A (zh) * 2018-04-26 2021-07-23 纳米医学控股有限公司 吉西他滨两亲性前体药物
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
JP2021534085A (ja) * 2018-08-03 2021-12-09 セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited 癌治療のための組成物及び方法
US12110311B2 (en) 2019-07-17 2024-10-08 Nucorion Pharmaceuticals, Inc. Cyclic deoxyribonucleotide compounds
WO2021216427A1 (en) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
DE69812934T2 (de) * 1997-01-24 2004-01-29 Conpharma As Oslo Gemcitabin-derivate
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
WO2004041203A2 (en) * 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
PL1831237T3 (pl) 2009-01-30
JP2008524218A (ja) 2008-07-10
MY143677A (en) 2011-06-30
CA2589850A1 (en) 2006-06-22
KR20070086308A (ko) 2007-08-27
CN101080417B (zh) 2011-01-19
TWI326687B (en) 2010-07-01
AU2005316922B2 (en) 2011-08-25
DE602005009255D1 (de) 2008-10-02
CY1108447T1 (el) 2014-04-09
EP1831237B1 (en) 2008-08-20
ZA200705019B (en) 2008-10-29
WO2006065525A1 (en) 2006-06-22
MX2007007228A (es) 2007-08-14
IL183666A (en) 2011-09-27
RS50629B (sr) 2010-06-30
CA2589850C (en) 2012-05-01
JP5022911B2 (ja) 2012-09-12
MA29154B1 (fr) 2008-01-02
KR100874052B1 (ko) 2008-12-12
EP1831237A1 (en) 2007-09-12
PT1831237E (pt) 2008-09-22
EA200701300A1 (ru) 2007-10-26
BRPI0519117A2 (pt) 2008-12-23
ATE405573T1 (de) 2008-09-15
EA011868B1 (ru) 2009-06-30
NZ554732A (en) 2010-09-30
NO20073368L (no) 2007-07-16
CN101080417A (zh) 2007-11-28
US20090156547A1 (en) 2009-06-18
HK1109903A1 (en) 2008-06-27
UA86119C2 (ru) 2009-03-25
HRP20080529T3 (en) 2008-12-31
US7691827B2 (en) 2010-04-06
TW200634023A (en) 2006-10-01
ES2310860T3 (es) 2009-01-16
IL183666A0 (en) 2007-09-20
PE20060771A1 (es) 2006-09-23
AR055009A1 (es) 2007-08-01
SI1831237T1 (sl) 2009-02-28
AU2005316922A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
DK1831237T3 (da) Amidprolægemiddel af gemcitabin, sammensætninger og anvendelse deraf
DK1937824T3 (da) Sammensætninger af tRNA og anvendelser deraf
DK1751087T3 (da) Levodopa-derivater og sammensætninger og anvendelser deraf
DK2057153T3 (da) (3-aryl-piperazin-1-yl)-derivater af 6,7 dialkoxyquinazolin, 6,7- dialkoxyphtalazin og 6,7-dialkoxyisoquinolin
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
DK3321359T3 (da) Variante former af uratoxidase og anvendelse deraf
DK3309233T4 (da) Sammensætninger omfattende hfc-1234yf og hfc-152a
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK1858864T3 (da) Stabiliserede sammensætninger af flygtige alkyleringsmidler og fremgangsmåder til anvendelse deraf
DK1877379T3 (da) Hydroxybenzamidderivater og anvendelse heraf som inhibitorer af hsp90
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK1931315T3 (da) Depotformuleringer af nalbufin
DK1959948T3 (da) Levodopa prodrug-mesylat, sammensætninger deraf og anvendelser deraf
DK1996557T3 (da) Pyridazinon-forbindelse og anvendelse deraf som herbicid
DK1824566T3 (da) Orale sammensætninger indeholdende ekstrakter af rosmaring og beslægtede metoder
NO345062B1 (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy) pyrimidinbaserte forbindelser og anvendelse derav
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
DK1804871T3 (da) Forbedret mellemstykke
DK2139334T3 (da) Kondenserede heterocykliske 2-cyanophenylforbindelser og sammensætninger og anvendelser deraf
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
FI20050195A (fi) Metalliseoksen käyttö
DK1976548T3 (da) VIP-fragmenter og sammensætninger deraf
DK1858481T3 (da) Ophthalmologiske sammensætninger og anvendelse deraf